进展期胃癌；介入化疗栓塞；手术治疗。
Treatment of Advanced Gastric Carcinoma by Gastric Art.......
目的评估多脏器联合切除术治疗进展期胃癌的临床效果。
Objective To evaluate the effect of combined multiple organ resection for patients with advanced gastric cancer (AGC).
首发症状不典型，病程长（平均1 5年） ，均为进展期胃癌；
These patients told atypical symptom, had a long course of disease(1.5 year averaged)and were diagnosed advanced gastric cancer.
结论术前动脉化疗能提高进展期胃癌患者的手术切除率和根治率。
Conclusion Preoperative arterial chemotherapy can elevate the resectable rate and radical rate of the patients with advenced gastric cancer underwent surgery.
目的探讨术前动脉化疗对进展期胃癌手术切除率和根治率的影响。
ObjectiveTo examine the effect of preoperative arterial chemotherapy on resectable rate and radical rate of the patients with advanced gastric cancer.
结论进展期胃癌淋巴结转移与浸润深度、分化程度和肿瘤长径有关。
ConclusionLymph node metastasis in advanced gastric carcinoma is correlated with the depth of invasion, histological type and tumor size.
目的 比较双路化疗与全身化疗治疗进展期胃癌的疗效和毒副反应。
Objective: To evaluate the effect of transcatheter arterial chemoembolization Combined with Chemotherapy for treating pancreatic carcinoma.
结论术前应用双路化疗，为高度进展期胃癌的综合治疗开辟了一条新途径。
Conclusions Two route-chemotherapy inaugurates a new route of treatment for the synthesis therapy of preoperative gastric cancer ascites.
腹膜转移是进展期胃癌根治术后最常见的复发形式，是导致死亡的重要原因。
IntroductionPeritoneal metastasis is the commonest form of recurrence and the most important cause of death of advanced gastric cancer after radical dissection.
结论多脏器联合切除术治疗进展期胃癌手术死亡率较低，并发症发生率是可接受的。
Conclusion Our study showed that combined multiple organ resection for patients with AGC can be performed with relatively low operative mortality and acceptable morbidity.
目的研究延期留置空肠穿刺造口管间断肠内营养在进展期胃癌术后辅助化疗中应用的可行性及其临床疗效。
Objective to study the feasibility and clinical effects of enteral nutrition by needle catheter jejunostomy (NCJ) tube in the postoperative adjuvant chemotherapy for patients of staged gastric cancer.
方法对146例进展期胃癌病人分组行腹腔热低渗液灌注及动脉插管化疗，并对其腹腔转移率、肝转移率及3年生存率对照研究。
Methods 146 patients were divided into treated and control group. The peritoneal and hepatic recurrence and 3 year survival rate of each group were analyzed.
替吉奥联合顺铂作为一种新的新辅助化疗方案，治疗胃癌总缓解率达76％，是目前为止进展期胃癌化疗方案中缓解率最高的方案。
S-1 combined with CDDP as a new neoadjuvant chemotherapy, is the most efficient therapy in advanced gastric cancer at present, it's CR can be over 76%.
替吉奥联合顺铂作为一种新的新辅助化疗方案，治疗胃癌总缓解率达76％，是目前为止进展期胃癌化疗方案中缓解率最高的方案。
S-1 combined with CDDP as a new neoadjuvant chemotherapy, is the most efficient therapy in advanced gastric cancer at present, it's CR can be over 76%.
应用推荐